🇺🇸 FDA
Patent

US 10798955

Compositions of particulate coformulation

granted A61KA61K9/00A61K9/14

Quick answer

US patent 10798955 (Compositions of particulate coformulation) held by Nektar Therapeutics expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K9/00, A61K9/14, A61K9/1652, A61K9/167